MedPath

Protocol for a Feasibility Cluster Randomised Controlled Trial of a Home-based Depression Care for Older People Delivered by Lay Providers in Nigeria

Not Applicable
Not yet recruiting
Conditions
Depression in Old Age
Registration Number
NCT06125899
Lead Sponsor
University of Ibadan
Brief Summary

The aim of this hybrid (Effectiveness-Implementation) cluster randomised controlled clinical trial is to test the feasibility of implementing an age-appropriate electronic version of the WHO Mental Health Gap Action Programme Intervention Guide (emhGAP-Age) in routine home-based care of older Nigerians with depression. The main questions it aims to answer are:

1. Whether the emhGAP-Age demonstrate sufficient signals of effectiveness in the identification and home management of late life depression to permit for further exploration in a fully powered clinical trial?

2. What are the logistical, programmatic, and operational requirements for a home-delivered emhGAP-Age in a sample of older people with depression in Nigeria? Consenting older participants with depression in the intervention arm will receive treatment based on emhGAP-Age which consists of;

* Adapted electronic generic version of the WHO Mental Health Gap Action Programme Intervention Guide (emhGAP-IG)

* Adapted Problem-Solving Therapy (PST-PC)

* Support/supervision of providers

* Links to social support resources. Researchers will compare with treatment based on the basic specification in the generic emhGAP-IG (consisting of basic psychoeducation and stress reduction) for effects on depression remission.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
110
Inclusion Criteria
  1. Age ≥ 60 years,
  2. PHQ-9 score of ≥11 during routine consultation
Exclusion Criteria
  1. Severe co-morbidity requiring urgent attention.
  2. Severe cognitive impairment/dementia (Community Screening Instruments for Dementia score≤ 20) .
  3. Active suicidal intention.
  4. Evidence of bipolar/psychosis/severe substance use disorders.
  5. Planning to move out of the study catchment area within 6 months.
  6. Refusing/lacking capacity to consent/accent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Depression remissionAt six months post trial entry

Patient Health Questionnaire (PHQ-9) score \< 6

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.